Search Results - "Kawamura, Kodai"

The ROX index (Index combining the respiratory rate with oxygenation) is a prognostic factor for acute respiratory distress syndrome by Nishiyama, Kenta, Ichikado, Kazuya, Anan, Keisuke, Nakamura, Kazunori, Kawamura, Kodai, Suga, Moritaka, Sakagami, Takuro

“…There is no existing reliable and practical method for predicting the prognosis of acute respiratory distress syndrome (ARDS). We aimed to clarify the…”
Get full text

The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study by Takaki, Makoto, Ichikado, Kazuya, Kawamura, Kodai, Gushima, Yasuhiro, Suga, Moritaka

“…The efficacy of corticosteroid use in acute respiratory distress syndrome (ARDS) remains controversial. Generally, short-term high-dose corticosteroid therapy…”
Get full text

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study by Kawamura, Kodai, Ichikado, Kazuya, Yasuda, Yuko, Anan, Keisuke, Suga, Moritaka

“…Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a fatal condition without an established pharmaceutical treatment. Most patients are treated…”
Get full text

Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia by Ichikado, Kazuya, Kawamura, Kodai, Johkoh, Takeshi, Fujimoto, Kiminori, Shintani, Ayumi, Hashimoto, Satoru, Eguchi, Yoshitomo, Yasuda, Yuko, Anan, Keisuke, Shingu, Naoki, Sakata, Yoshihiko, Hisanaga, Junpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nishiyama, Kenta, Nakamura, Kazunori, Suga, Moritaka, Ichiyasu, Hidenori, Sakagami, Takuro

“…There have been no report of objective clinical characteristics or prognostic factors that predict fatal outcome of acute respiratory distress syndrome (ARDS)…”
Get full text

Dendriform Pulmonary Ossification by Anan, Keisuke, Hisanaga, Jumpei, Kawamura, Kodai, Ichikado, Kazuya

Get full text

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis by Anan, Keisuke, Kataoka, Yuki, Ichikado, Kazuya, Kawamura, Kodai, Johkoh, Takeshi, Fujimoto, Kiminori, Tobino, Kazunori, Tachikawa, Ryo, Ito, Hiroyuki, Nakamura, Takahito, Kishaba, Tomoo, Inomata, Minoru, Kamitani, Tsukasa, Yamazaki, Hajime, Ogawa, Yusuke, Yamamoto, Yosuke

“…Although corticosteroid therapy with dose tapering is the most commonly used treatment for acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), there…”
Get full text

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience by Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro

“…Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP)…”
Get full text

Correction: Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis by Anan, Keisuke, Kataoka, Yuki, Ichikado, Kazuya, Kawamura, Kodai, Johkoh, Takeshi, Fujimoto, Kiminori, Tobino, Kazunori, Tachikawa, Ryo, Ito, Hiroyuki, Nakamura, Takahito, Kishaba, Tomoo, Inomata, Minoru, Kamitani, Tsukasa, Yamazaki, Hajime, Ogawa, Yusuke, Yamamoto, Yosuke

Get full text

Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study by Kawamura, Kodai, Ichikado, Kazuya, Anan, Keisuke, Yasuda, Yuko, Sekido, Yuko, Suga, Moritaka, Ichiyasu, Hidenori, Sakagami, Takuro

“…Recent studies have suggested that an increased peripheral monocyte count predicts a poor outcome in fibrosing interstitial lung disease (ILD). However, the…”
Get full text

Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease by Nitawaki, Tatsuya, Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya

“…Alectinib, a second-generation anaplastic lymphoma kinase (ALK) inhibitor, is a key drug for ALK rearranged lung adenocarcinoma. Interstitial lung disease…”
Get full text

A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer by Kawamura, Kodai, Matsushima, Hidekazu, Sakai, Hiroshi, Iwashima, Akira, Nakamura, Sukeyuki, Kojima, Tohru, Sasaki, Shinichi, Shigenaga, Takehiko, Natsume, Ichiro, Sasaki, Takaaki, Ohsaki, Yoshinobu, Iwanaga, Kentaro, Nishi, Koichi, Mitsuishi, Yoichiro, Taniguchi, Hirokazu, Sato, Kazuhiro, Yamauchi, Mitsugu, Nakajima, Motowo, Takahashi, Kazuhisa

“…Cisplatin-based chemotherapy was established in the 1980s, and it has been improved by the development of a short hydration protocol in lung cancer therapy…”
Get more information

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J) by Ichikado, Kazuya, Ichiyasu, Hidenori, Iyonaga, Kazuhiro, Kawamura, Kodai, Higashi, Noritaka, Johkoh, Takeshi, Fujimoto, Kiminori, Morinaga, Jun, Yoshida, Minoru, Mitsuzaki, Katsuhiko, Suga, Moritaka, Tanabe, Naoya, Handa, Tomohiro, Hirai, Toyohiro, Sakagami, Takuro

“…Interstitial lung abnormalities (ILAs) are subtle or mild parenchymal abnormalities observed in more than 5% of the lungs on computed tomography (CT) scans in…”
Get full text

Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis by Teruya, Aoi, MD, Kawamura, Kodai, MD, PhD, Ichikado, Kazuya, MD, PhD, Sato, Shinji, MD, PhD, Yasuda, Yuko, MD, Yoshioka, Masakazu, MD, PhD

“…Clinically amyopathic dermatomyositis (CADM), a subtype of dermatomyositis with subtle or no muscle involvement, is occasionally accompanied by fatal, rapidly…”
Get full text

Algorithms Identifying Patients With Acute Exacerbation of Interstitial Pneumonia and Acute Interstitial Lung Diseases Developed Using Japanese Administrative Data by Anan, Keisuke, Kataoka, Yuki, Ichikado, Kazuya, Kawamura, Kodai, Yasuda, Yuko, Hisanaga, Junpei, Nitawaki, Tatsuya, Yamamoto, Yosuke

“…We aimed to develop algorithms to identify patients with acute exacerbation of interstitial pneumonia and acute interstitial lung diseases using Japanese…”
Get full text

The Accuracy of Japanese Administrative Data in Identifying Acute Exacerbation of Idiopathic Pulmonary Fibrosis by Anan, Keisuke, Kataoka, Yuki, Ichikado, Kazuya, Kawamura, Kodai, Johkoh, Takeshi, Fujimoto, Kiminori, Tobino, Kazunori, Tachikawa, Ryo, Ito, Hiroyuki, Nakamura, Takahito, Kishaba, Tomoo, Inomata, Minoru, Yamamoto, Yosuke

“…BACKGROUNDThis study aimed to develop criteria for identifying patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) from Japanese…”
Get full text

Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019 by Goto, Yasushi, Kawamura, Kodai, Fukuhara, Tatsuro, Namba, Yukiko, Aoe, Keisuke, Shukuya, Takehito, Tsuda, Takeshi, Santorelli, Melissa L., Taniguchi, Kazuko, Kamitani, Tetsu, Irisawa, Masato, Kanda, Kingo, Abe, Machiko, Burke, Thomas, Nokihara, Hiroshi

“…First-line immune checkpoint inhibitor (ICI) monotherapy for advanced non–small cell lung cancer (NSCLC) was introduced in Japan in February 2017. Limited…”
Get full text

Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study by Ichikado, Kazuya, Muranaka, Hiroyuki, Gushima, Yasuhiro, Kotani, Toru, Nader, Habashi M, Fujimoto, Kiminori, Johkoh, Takeshi, Iwamoto, Norihiro, Kawamura, Kodai, Nagano, Junji, Fukuda, Koichiro, Hirata, Naomi, Yoshinaga, Takeshi, Ichiyasu, Hidenori, Tsumura, Shinsuke, Kohrogi, Hirotsugu, Kawaguchi, Atsushi, Yoshioka, Masakazu, Sakuma, Tsutomu, Suga, Moritaka

“…ObjectivesTo examine whether the extent of fibroproliferative changes on high-resolution CT (HRCT) scan influences prognosis, ventilator dependency and the…”
Get full text

Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors by Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Shingu, Naoki, Yasuda, Yuko, Eguchi, Yoshitomo, Hisanaga, Jumpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nakano, Aiko, Sakagami, Takuro

“…Background The use of baseline tumor burden (TB) as a prognostic factor for non‐small cell lung cancer (NSCLC) patients treated with immune checkpoint…”
Get full text

Differentiation, maturation, and survival of dendritic cells by osteopontin regulation by Kawamura, Kodai, Iyonaga, Kazuhiro, Ichiyasu, Hidenori, Nagano, Junji, Suga, Moritaka, Sasaki, Yutaka

“…Dendritic cells (DCs) are antigen-presenting cells with the ability to induce primary immune responses necessary in innate immunity and adaptive immunity…”
Get full text

A Case of Orbital Metastasis as Disease Progression of Anaplastic Lymphoma Kinase-Positive Lung Cancer Treated with Crizotinib by Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Yoshioka, Masakazu

“…Orbital metastasis of lung cancer is rare. It often causes visual disorder. To date, there are only a few case reports. Crizotinib is an anaplastic lymphoma…”
Get full text